Pharma Blog Watch
Mired
in the Negative? (DrugWonks.com)
How should the FDA counter all of the
negative media coverage that's been circling in recent months? In a short entry,
blogger Peter Pitts cites examples of what's working and what's not working at
the FDA.
GSK Leads the
Charge (EyeOnFDA.com)
Last week, GlaxoSmithKline (GSK) announced that it
will publish detailed summaries of its clinical trials on a public website. Blogger
Mark Senak praises this move, and notes that other companies should take GSK's
transparency cue.
The
Hubub Over Transgenically-Derived Treatments (PatentBaristas.com)
The European
Committee has recommended GTC Biotherapeutics' injectable antithrombin drug, ATryn,
for approval. In her entry, blogger Nicole Tepe discusses the debate in the medical
community regarding animal-derived antithrombin, and speculates on the progress
of this type of treatment if ATryn is granted final approval.